Search

… Job Title Manager, Drug Development, MSK Therapeutics Bridge Labs Nora Kostow is Manager, Drug Development in the MSK Therapeutics Bridge Labs (TxBL) program, in the Office of Entrepreneurship & Commercialization, where she does early-stage drug discovery research. She joined MSK in September 2025. Nora

The MSK team’s goal was to get at the underlying defects in cells that these mutations cause.

… Monday, July 1, 2019 Summary MSK researchers have made new discoveries about how changes in a family of cancer-causing genes can lead to epigenetic changes. A family of genes called IDH are associated with cancer. These genes make enzymes called isocitrate dehydrogenases. The enzymes help break down

Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.

… Dr. Sawyers is an HHMI Investigator searching for molecularly targeted approaches to treat cancer. He has identified cell signaling components critical to the growth of cancer cells in chronic myeloid leukemia, prostate and other cancers, resulting in the development of multiple FDA-approved inhibitors

… Job Title Administrative Assistant Email [email protected] Office Phone 212-639-7090

… In this online support group, MSK Kids caregivers can connect with and gain support from other caregivers. It offers the space to share common feelings, learn coping strategies, and talk about the experiences of caregiving for a child receiving treatment at MSK Discussions are led by MSK Kids social

… Job Title Postdoctoral Researcher Education PhD, University of Basel (Applied Statistics); MS, University of Edinburgh (Intelligent Robotics); BEng, College of Engineering, Chengannur, Kerala (Computer Engineering) Email [email protected]

Oncologist and hematologist Ellin Berman describes how a team of experts provides a variety of therapeutic options to patients with leukemia, from standard of care treatments to new therapies available in clinical trials.

… Oncologist and hematologist Ellin Berman describes how a team of experts provides a variety of therapeutic options to patients with leukemia , from standard of care treatments to new therapies available in clinical trials.

Questions and answers about donating to a specific patient, self-donations for future use, platelet and whole blood donations.

… Certain cancer treatments reduce the number of blood cells patients have in their bodies. A reduced supply of red blood cells can cause anemia and a feeling of weakness. A reduction of platelets may increase the risk for bleeding. Our patients depend on volunteers in the community to donate blood and

… Job Title Clinical Fellow Degree MD End Year 2024

… Job Title Post-doctoral Fellow Degree PhD